Fig. 2: Presenting disease burden of newly diagnosed myeloma patients, those diagnosed from 1st January 2019–31st January 2020 (Pre-C, n = 110) and those diagnosed from 1st February 2020–31st July 2021 (Post-C, n = 213). | Blood Cancer Journal

Fig. 2: Presenting disease burden of newly diagnosed myeloma patients, those diagnosed from 1st January 2019–31st January 2020 (Pre-C, n = 110) and those diagnosed from 1st February 2020–31st July 2021 (Post-C, n = 213).

From: Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic

Fig. 2

*p < 0.05, **p < 0.01, ns Not Significant, ISS International Staging System, MBD myeloma bone disease (>3 lytic lesions) EMD extra-medullary disease.

Back to article page